259Abstract INHIBITORS OF SPHINGOSINE KINASEThe present invention relates to compounds of the formula (I), where RI, R2, R3, R4, R5,6 7 8 9 10 11 12 13 14 15 16 17R,R,R,R,R ,R ,R ,R ,R ,R ,R ,R , MI, M2, M3, M4, Y1, Y2, V, W,n,mand o have the meaning specified in claim 1, and to physiologically compatible salts, derivatives, prodrugs, solvates, tautomers and stereoisomers thereof, including mixtures thereof in all ratios, for use in the treatment of diseases that are influenced by inhibiting sphingosine kinase 1.No figure